MLCMalin Corporation plc

ISE · IE · Healthcare · Drug Manufacturers - Specialty & Generic · malinplc.com

7.000EUR0.00%Mkt Cap: 32.92M $P/E: Infinity4d ago

Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic a…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap32.92M $

Enterprise Value18.96M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)0 $

Revenue/Share—

Last Price7.000 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees2

CountryIE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)Infinity

P/E (Forward)-58.33

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.79

EPS (TTM)0.00

EPS (Forward)-0.12

52W Range

6.8008% of range9.300

52W High9.300 EUR

52W Low6.800 EUR

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE0.00%

ROA0.00%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.41M $

CapEx (TTM)—

FCF Margin—

FCF Yield-3.01%

Net Debt-14.02M $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.00

Current Ratio16.13

Quick Ratio16.13

Book Value/Sh8.904 EUR

Cash/Share2.976 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 EUR

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)15.50 EUR

Upside (mean)+121.4%

Target Range15.50 EUR – 15.50 EUR

# Analysts1

Ownership

Shares Out.4.33M

Float892.64K

Insiders34.96%

Institutions44.29%

Technical

SMA 507.189 (-2.6%)

SMA 2007.654 (-8.5%)

Beta0.42

S&P 52W Chg18.16%

Avg Vol (30d)30

Avg Vol (10d)59

Technical Indicators

RSI (14)30.9

MACD-0.0897

MACD Signal-0.0983

MACD Hist.+0.0086

BB Upper7.227 EUR

BB Middle7.070 EUR

BB Lower6.913 EUR

BB Width4.44%

ATR (14)0.0412 EUR

Vol Ratio (20d)0.00x